NAD+, NMN, and NR can be confusing because they are all related to the same molecule and are marketed as ways to boost your NAD+ levels. However, they are not interchangeable. Knowing the differences between NAD, NMN, and NR is important for making an informed choice that fits your health goals.
Starting with the Basics
NAD+ (nicotinamide adenine dinucleotide) is the active molecule your cells need. It is the end product, which is what you want to increase. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are both precursors to NAD+, so your body uses them as raw materials to make NAD+. You can think of NAD+ as the finished product, while NMN and NR are two different ingredients your body uses to create it.
NMN: One Step Away from NAD+
NMN is the immediate precursor to NAD+ in the salvage pathway, which is the primary route your body uses to recycle and regenerate NAD+. When you take NMN, your body needs only one enzymatic step to convert it into active NAD+. This relative closeness to the end product is one of the reasons NMN has generated significant research interest. Animal studies have shown that NMN supplementation effectively increases NAD+ levels and improves metabolic function, exercise capacity, and age-related biomarkers.
NMN is available as an oral supplement and has been shown in early human trials to be safe and well-tolerated. However, questions remain about how efficiently oral NMN survives digestion and how much ultimately reaches cells as active NAD+.
NR: Two Steps Away from NAD+
Nicotinamide riboside is another NAD+ precursor, but it sits one step further back in the biosynthetic pathway. NR must first be converted to NMN, and then NMN is converted to NAD+. NR has the advantage of having more published human clinical trial data than NMN. A 2018 study in Nature Communications demonstrated that chronic NR supplementation safely increased NAD+ levels in healthy middle-aged and older adults. NR is widely available as an oral supplement under several brand names.
Direct NAD+ Therapy: Skipping the Conversion
The third option is direct NAD+ administration through injections or IV infusions. This approach skips the conversion steps entirely—you're delivering the active molecule itself. The advantage is efficiency: there's no reliance on enzymatic conversion, no variability in absorption from the gut, and no question about how much NAD+ is actually reaching your cells. The tradeoff is practicality: injections and IVs are more involved than taking a pill and typically cost more.
Head-to-Head: How They Compare
When comparing NAD vs NMN from an effectiveness standpoint, direct NAD+ delivery provides the most reliable elevation of NAD+ levels because it bypasses all conversion steps. NMN is the next most direct, requiring only one conversion. NR requires two. In terms of convenience, oral NMN and NR win—they're available as capsules you take daily. Direct NAD+ requires injections or IV sessions. Cost varies, but generally oral supplements are the least expensive, injections are moderate, and IV infusions are the most expensive option.
From an evidence standpoint, NR has the most published human clinical data among the oral options. NMN's human data is growing rapidly. Direct NAD+ injection therapy has strong mechanistic support and extensive clinical use, though large-scale randomized human trials specifically on injection protocols are still limited.
Which Should You Choose?
The best choice depends on your priorities. If you want the most efficient, reliable NAD+ elevation and are comfortable with injections, direct NAD+ therapy is the most straightforward path. If you prefer the convenience of oral supplementation and want a well-researched option, NR has the strongest clinical evidence among oral precursors. NMN is a reasonable choice for those who want an oral supplement that's one step closer to NAD+ than NR, acknowledging that its human evidence base is still catching up.
At HRT Wellness, we can help you evaluate the best approach for your situation. Schedule a consultation to discuss your options.
References
- Yoshino J, Baur JA, Imai S. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27(3):513–528.
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+. Nature Communications. 2018;9(1):1286.
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229.